These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24305610)
21. The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue. Zucchi A; Costantini E; Scroppo FI; Silvani M; Kopa Z; Illiano E; Petrillo MG; Cari L; Nocentini G Andrology; 2019 Nov; 7(6):804-817. PubMed ID: 31350821 [TBL] [Abstract][Full Text] [Related]
22. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis. Limoncin E; Gravina GL; Corona G; Maggi M; Ciocca G; Lenzi A; Jannini EA Andrology; 2017 Sep; 5(5):863-872. PubMed ID: 28787547 [TBL] [Abstract][Full Text] [Related]
23. Decision tree analyses of key patient characteristics in Middle Eastern/North African and Latin American men treated with long-acting and short-acting PDE5 inhibitors for erectile dysfunction. Rubio-Aurioles E; El-Meliegy A; Abdulwahed S; Henneges C; Sorsaburu S; Gurbuz S Curr Med Res Opin; 2015 Feb; 31(2):367-78. PubMed ID: 25068906 [TBL] [Abstract][Full Text] [Related]
24. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study. Lee J; Pommerville P; Brock G; Gagnon R; Mehta P; Krisdaphongs M; Chan M; Chan J; Dickson R BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764 [TBL] [Abstract][Full Text] [Related]
25. A treatment algorithm for healthy young men with erectile dysfunction. Wiggins A; Tsambarlis PN; Abdelsayed G; Levine LA BJU Int; 2019 Jan; 123(1):173-179. PubMed ID: 29993196 [TBL] [Abstract][Full Text] [Related]
26. The self-estimation index of erectile function-no sexual intercourse (SIEF-NS): a multidimensional scale to assess erectile dysfunction in the absence of sexual intercourse. Yuan Y; Zhang Z; Gao B; Peng J; Cui W; Song W; Xin Z; Guo Y J Sex Med; 2014 May; 11(5):1201-7. PubMed ID: 24589237 [TBL] [Abstract][Full Text] [Related]
27. PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction. Labairu-Huerta L; Padilla-Fernández B; Arrondo-Arrondo JL; Valverde-Martínez LS; Martín-Rodríguez A; Silva-Abuín JM; García-Cenador MB; Mirón-Canelo JA; Lorenzo-Gómez MF Arch Ital Urol Androl; 2015 Sep; 87(3):204-9. PubMed ID: 26428641 [TBL] [Abstract][Full Text] [Related]
28. The effect of CPAP and PDE5i on erectile function in men with obstructive sleep apnea and erectile dysfunction: A systematic review and meta-analysis. Li Z; Fang Z; Xing N; Zhu S; Fan Y Sleep Med Rev; 2019 Dec; 48():101217. PubMed ID: 31715462 [TBL] [Abstract][Full Text] [Related]
29. Recreational use of phosphodiesterase type 5 inhibitors by healthy young men. Bechara A; Casabé A; De Bonis W; Helien A; Bertolino MV J Sex Med; 2010 Nov; 7(11):3736-42. PubMed ID: 20722788 [TBL] [Abstract][Full Text] [Related]
30. Exploring the association between erectile rigidity and treatment adherence with sildenafil. Mazzola CR; Deveci S; Teloken P; Mulhall JP J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943 [TBL] [Abstract][Full Text] [Related]
31. Back to baseline: erectile function recovery after radical prostatectomy from the patients' perspective. Nelson CJ; Scardino PT; Eastham JA; Mulhall JP J Sex Med; 2013 Jun; 10(6):1636-43. PubMed ID: 23551767 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline. Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781 [TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of intraurethral alprostadil in patients with erectile dysfunction refractory to treatment using phosphodiesterase-5 inhibitors. Garrido Abad P; Sinués Ojas B; Martínez Blázquez L; Conde Caturla P; Fernández Arjona M Actas Urol Esp; 2015 Dec; 39(10):635-40. PubMed ID: 26049734 [TBL] [Abstract][Full Text] [Related]
35. Psychometric validation of the Confidence in Performing Sexual Intercourse Questionnaire and Difficulty in Performing Sexual Intercourse Questionnaire. Hayes RP; Seftel A; Rosen RC; Althof S; Shen W; Shih T; Sontag A Int J Impot Res; 2014; 26(3):105-11. PubMed ID: 24335748 [TBL] [Abstract][Full Text] [Related]
36. Effect of once-daily tadalafil on confidence and perceived difficulty in performing sexual intercourse in men who were incomplete responders to as-needed PDE5 inhibitor treatment. Seftel AD; Rosen RC; Hayes RP; Althof S; Goldfisher E; Shen W; Sontag A Int J Clin Pract; 2014 Jul; 68(7):841-9. PubMed ID: 24666765 [TBL] [Abstract][Full Text] [Related]
37. The role of initial success rates and other factors in determining reliability of outcomes of phosphodiesterase inhibitor therapy for erectile dysfunction: a pooled analysis of 17 placebo-controlled trials of tadalafil for use as needed. Sontag A; Rosen RC; Litman HJ; Ni X; Araujo AB J Sex Med; 2013 Feb; 10(2):541-50. PubMed ID: 22905853 [TBL] [Abstract][Full Text] [Related]
38. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study. Chevret-Méasson M; Lavallée E; Troy S; Arnould B; Oudin S; Cuzin B J Sex Med; 2009 Mar; 6(3):761-9. PubMed ID: 19143916 [TBL] [Abstract][Full Text] [Related]
39. Inflammatory biomarkers may predict response to phosphodiesterase type 5 inhibitor treatment in patients with erectile dysfunction. Kilic M; Erkan A; Zengin S; Dundar G; Boyaci C Investig Clin Urol; 2023 Jul; 64(4):404-411. PubMed ID: 37417566 [TBL] [Abstract][Full Text] [Related]
40. PDE5 inhibitor treatment persistence and adherence in Brazilian men: post-hoc analyses from a 6-month, prospective, observational study. Cairoli C; Reyes LA; Henneges C; Sorsaburu S Int Braz J Urol; 2014; 40(3):390-9. PubMed ID: 25010306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]